Lyell Immunopharma | DEFA14A: Others
Apr 23 04:22
Lyell Immunopharma | DEF 14A: Definitive information statements
Apr 23 04:17
Lyell Immunopharma | S-3: Registration statement for specified transactions by certain issuers
Mar 1 02:35
Lyell Immunopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 1 02:35
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
Feb 29 05:15
Lyell Immunopharma | 8-K: Current report
Nov 21, 2023 05:26
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
Nov 8, 2023 05:08
Lyell Immunopharma | 8-K: Current report
Sep 11, 2023 21:16
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
Aug 9, 2023 04:10
Lyell Immunopharma | 8-K: Current report
Jun 22, 2023 04:54
Lyell Immunopharma | 8-K: Current report
Jun 7, 2023 04:02
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
May 5, 2023 04:11
Lyell Immunopharma | DEFA14A: Others
Apr 28, 2023 04:08
Lyell Immunopharma | DEF 14A: Definitive proxy statements
Apr 28, 2023 04:06
Lyell Immunopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 1, 2023 06:30
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022
Mar 1, 2023 05:11
Lyell Immunopharma | 8-K: Current report
Dec 17, 2022 05:02
Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
Nov 9, 2022 05:07
Lyell Immunopharma | 8-K: Current report
Oct 25, 2022 05:20
Lyell Immunopharma | 8-K: Current report
Oct 7, 2022 04:37
No Data
No Data